BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24269017)

  • 1. [Helical tomotherapy in the treatment of malignant pleural mesothelioma: The impact of low doses on pulmonary and oesophageal toxicity].
    Helou J; Clément-Colmou K; Sylvestre A; Campion L; Amessis M; Zefkili S; Raphael J; Bonnette P; Le Pimpec Barthes F; Périgaud C; Mahé MA; Giraud P
    Cancer Radiother; 2013 Dec; 17(8):755-62. PubMed ID: 24269017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma.
    Kishan AU; Cameron RB; Wang PC; Alexander S; Qi SX; Low DA; Kupelian PA; Steinberg ML; Lee JM; Selch MT; Lee P
    Pract Radiat Oncol; 2015; 5(6):366-73. PubMed ID: 26432677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment.
    Parisi E; Romeo A; Sarnelli A; Ghigi G; Bellia SR; Neri E; Micheletti S; Dipalma B; Arpa D; Furini G; Burgio MA; Genestreti G; Gurioli C; Sanna S; Bovolato P; Rea F; Storme G; Scarpi E; Arienti C; Tesei A; Polico R
    Cancer Radiother; 2017 Dec; 21(8):766-773. PubMed ID: 29132803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung.
    Minatel E; Trovo M; Polesel J; Rumeileh IA; Baresic T; Bearz A; Del Conte A; Franchin G; Gobitti C; Drigo A; Dassie A; Pagan V; Trovo MG
    J Thorac Oncol; 2012 Dec; 7(12):1862-1866. PubMed ID: 23154558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy.
    Thieke C; Nicolay NH; Sterzing F; Hoffmann H; Roeder F; Safi S; Debus J; Huber PE
    Radiat Oncol; 2015 Dec; 10():267. PubMed ID: 26715491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity modulated radiation therapy after extra-pleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival.
    Jhavar S; Pruszynski J; Gowan A; Boyle T; Deb N; Patel M
    Asia Pac J Clin Oncol; 2018 Apr; 14(2):e88-e94. PubMed ID: 28371288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
    Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric Comparison of Lung-Sparing Radiation Therapy between Volumetric Arc Therapy and Helical Tomotherapy for Unresectable Malignant Pleural Mesothelioma.
    Pehlivan B; Sengul K; Yesil A; Nalbant N; Ozturk O; Ozdemir Y; Topkan E
    Biomed Res Int; 2019; 2019():4568958. PubMed ID: 31930123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT.
    Sterzing F; Sroka-Perez G; Schubert K; Münter MW; Thieke C; Huber P; Debus J; Herfarth KK
    Radiother Oncol; 2008 Feb; 86(2):251-7. PubMed ID: 18207597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-Modulated Radiation Therapy Improves the Target Coverage Over 3-D Planning While Meeting Lung Tolerance Doses for All Patients With Malignant Pleural Mesothelioma.
    Ulger S; Cetin E; Catli S; Sarac H; Kilic D; Bora H
    Technol Cancer Res Treat; 2017 Jun; 16(3):332-338. PubMed ID: 28462689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma.
    Kristensen CA; Nøttrup TJ; Berthelsen AK; Kjaer-Kristoffersen F; Ravn J; Sørensen JB; Engelholm SA
    Radiother Oncol; 2009 Jul; 92(1):96-9. PubMed ID: 19364621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of tomotherapy in malignant pleural mesothelioma: first clinical results].
    Giraud P; Sylvestre A; Lisbona A; Zefkili S; Bonnette P; Le Pimpec Barthes F; Michaud JL; Perigaud C; Mahé MA
    Rev Mal Respir; 2011 May; 28(5):609-17. PubMed ID: 21645831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesothelioma at era of helical tomotherapy: results of two institutions in combining chemotherapy, surgery and radiotherapy.
    Sylvestre A; Mahé MA; Lisbona A; Zefkili S; Savignoni A; Bonnette P; Barthes Fle P; Paris E; Perigaud C; Yassa M; Giraud P
    Lung Cancer; 2011 Dec; 74(3):486-91. PubMed ID: 21663996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helical tomotherapy for resected malignant pleural mesothelioma: dosimetric evaluation and toxicity.
    Giraud P; Sylvestre A; Zefkili S; Lisbona A; Bonnette P; Le Pimpec Barthes F; Paris E; Perigaud C; Savignoni A; Mahé MA
    Radiother Oncol; 2011 Nov; 101(2):303-6. PubMed ID: 21864923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tomotherapy in malignant mesothelioma: a planning study to establish dose constraints.
    Leitzen C; Wilhelm-Buchstab T; Stumpf S; Heimann M; Koch D; Schmeel C; Simon B; Vornholt S; Garbe S; Röhner F; Schoroth F; Schild HH; Schüller H; Müdder T
    Strahlenther Onkol; 2019 Jul; 195(7):668-676. PubMed ID: 30915490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.
    Chance WW; Rice DC; Allen PK; Tsao AS; Fontanilla HP; Liao Z; Chang JY; Tang C; Pan HY; Welsh JW; Mehran RJ; Gomez DR
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):149-56. PubMed ID: 25442335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric Correlates of Pulmonary Toxicity in Patients with Malignant Pleural Mesothelioma Receiving Radiation Therapy to the Intact Lungs.
    Thompson MR; Dumane VA; Lazarev SA; Zia Y; Rosenzweig KE
    Pract Radiat Oncol; 2019 May; 9(3):e331-e337. PubMed ID: 30654090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric Comparison Between Helical Tomotherapy and Volumetric Modulated Arc Therapy in Patients With Malignant Pleural Mesothelioma.
    Müdder T; Sarria GR; Henkenberens C; Holz J; Garbe S; Röhner F; Stumpf S; Buchstab T; Giordano FA; Leitzen C
    Clin Oncol (R Coll Radiol); 2022 Mar; 34(3):164-171. PubMed ID: 34429236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extra-pleural pneumonectomy in the era of image-guided intensity-modulated radiotherapy.
    Trovo M; Franceschini D; Furlan C; Pietrobon F; Vagge S; Farina E; Revelant A; Visani L; Maragna V; Parisi G; Scotti V
    Radiol Med; 2019 Sep; 124(9):854-859. PubMed ID: 30963379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.